中国药业2025，Vol.34Issue(16)：14-21,8.DOI:10.3969/j.issn.1006-4931.2025.16.003
京津冀生物医药领域技术创新实力分析
Analysis of the Technological Innovation Strength in the Biopharmaceutical Field in the Beijing-Tianjin-Hebei Region
摘要
Abstract
Objective To analyze the technological innovation strength in the biopharmaceutical field in the Beijing-Tianjin-Hebei region.Methods The data of invention patents in the biopharmaceutical field in the Beijing-Tianjin-Hebei region from 2022 to 2024 from the establishment of the database to February 13,2025 were collected through the Patsnap Patent Database,and patent measurement analysis was carried out from the perspectives of the number of invention patent applications,legal status,patentees,and direction of technological innovation.Results From 2022 to 2024,a total of 61 005 invention patent families were filed in biopharmaceutical field in the Beijing-Tianjin-Hebei region,with Beijing,Tianjin,and Hebei contributed 44 786,8 527,and 7 947 patent families,respectively.Over 60%of the invention patent families in the Beijing-Tianjin-Hebei region were in the ″under examination″ status.The proportion of ″valid″ patents 27.40%in Beijing was highest.Enterprises and universities/research institutions were the most active invention patent assignees in Beijing-Tianjin-Hebei region,with Tsinghua University,Tianjin University,and Yanshan University led technological innovations in the biopharmaceutical field of Beijing,Tianjin,and Hebei,respectively.Beijing showed relative advantages in genetic engineering,medical diagnosis,detection technologies and other fields,while Tianjin excelled in microbial technology,pharmaceutical formulations,anti-tumor drugs,drug carriers and other aspects.The two places showed completely complementary characteristics.Hebei showed relative advantages in material analysis,microbial technology,drug carriers,genetic engineering and other fields,which were overlapping with the above two places.Conclusion The biopharmaceutical innovation system in the Beijing-Tianjin-Hebei region has demonstrated strong competitiveness and synergistic effects.Each place leverages its technological advantages to jointly promote high-quality development of the regional industry.This study reveals the strength of regional technological innovation in the Beijing-Tianjin-Hebei region,which can provide data support and decision-making references for industrial technological innovation.关键词
京津冀/生物医药/发明专利/专利分析/技术创新Key words
Beijing-Tianjin-Hebei region/biopharmaceutical/invention patent/patent analysis/technological innovation分类
医药卫生引用本文复制引用
张婷,卢岩,陈娟,徐东紫,严舒,欧阳昭连..京津冀生物医药领域技术创新实力分析[J].中国药业,2025,34(16):14-21,8.基金项目
北京市社会科学基金项目(重点项目)[24JCB024]. （重点项目）
